BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 29334924)

  • 1. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
    Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
    BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
    Nazari H; Rao NA
    Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.
    Lertsumitkul S; Whitcup SM; Nussenblatt RB; Chan CC
    Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):1039-45. PubMed ID: 10654175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
    Han YS; Shin KS; Lee WH; Kim JY
    Ophthalmologica; 2018; 239(2-3):143-150. PubMed ID: 29339644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Treatment of Subretinal Fibrosis Caused Macular Detachment in Vogt-Koyanagi-Harada Disease: A Pioneer Study.
    Zhao C; Zhang M; Gao F; Dong F
    Ocul Immunol Inflamm; 2018; 26(1):154-159. PubMed ID: 27494778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease.
    Kuo IC; Rechdouni A; Rao NA; Johnston RH; Margolis TP; Cunningham ET
    Ophthalmology; 2000 Sep; 107(9):1721-8. PubMed ID: 10964836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of macular cone photoreceptors in Vogt-Koyanagi-Harada disease.
    Nakamura T; Hayashi A; Oiwake T
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):387-394. PubMed ID: 29264653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids.
    Sakata VM; da Silva FT; Hirata CE; Marin ML; Rodrigues H; Kalil J; Costa RA; Yamamoto JH
    Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):785-90. PubMed ID: 25592477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
    Yamaguchi Y; Otani T; Kishi S
    Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
    Lee GE; Lee BW; Rao NA; Fawzi AA
    Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOME-SHAPED MACULA IN MYOPIC EYES: Twelve-Month Follow-up.
    Lorenzo D; Arias L; Choudhry N; Millan E; Flores I; Rubio MJ; Cobos E; García-Bru P; Filloy A; Caminal JM
    Retina; 2017 Apr; 37(4):680-686. PubMed ID: 28333783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
    Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
    Parc C; Guenoun JM; Dhote R; Brézin A
    Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome.
    Golzarri MF; Cheja-Kalb R; Concha-Del-Río LE; Gonzalez-Salinas R; Arellanes-García L
    Ocul Immunol Inflamm; 2022 Feb; 30(2):265-269. PubMed ID: 33021860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
    Tsujikawa A; Yamashiro K; Yamamoto K; Nonaka A; Fujihara M; Kurimoto Y
    Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral domain optical coherence tomography of Vogt-Koyanagi-Harada disease: novel findings and new insights into the pathogenesis.
    Zhao C; Zhang MF; Dong FT; Wang XQ; Wen X; Dai RP; Yu WH; Zhang ZQ; Yang ZK; Gao F
    Chin Med Sci J; 2012 Mar; 27(1):29-34. PubMed ID: 22734211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The fundus manifestations and SD-OCT findings of patients with acute Vogt-Koyanagi-Harada disease].
    Li B; Ye JJ; Zhang MF; Li DH
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):436-439. PubMed ID: 28606265
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic Function of 3D Optical Coherence Tomography Images in Diagnosis of Vogt-Koyanagi-Harada Disease at Acute Uveitis Stage.
    Zhao GL; Li RZ; Pang YH; Wang XQ; Peng HJ; Wei JF; Zhou Z
    Med Sci Monit; 2018 Feb; 24():687-697. PubMed ID: 29396390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Subretinal Fluid Optical Density Ratio Differ Among the Eyes with Acute Central Serous Chorioretinopathy,Vogt Koyanagi Harada Disease and Choroidal Hemangioma: A Cross-sectional Study.
    Durmaz Engin C; Kayabasi M; Koksaldi S; Ipek SC; Saatci AO
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103634. PubMed ID: 37244453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.